Oral Rapid E-Poster Guidelines

Home » Abstracts » Oral Rapid E-Poster Guidelines

Oral Rapid E-Poster Guidelines

Presentation Date & Time: This will be shared closer to the Meeting Dates
Presentation Length: 3 minutes + 2 minutes Q&A
Presentation Media: Single-page PDF e-poster

All e-poster presenters will be notified by mid-late March 2025 of their acceptance by email. We will notify e-poster presenters of their e-poster session date, time, and e-poster stage number in late April. There will be six (6) e-poster stages in the Exhibition Hall. 

To prepare for your presentation at the 2025 Annual Meeting, please refer to the information below.

Complete the Following Tasks

  • Ensure that one (1) co-author is registered by the Early Bird Deadline. All abstracts must have one (1) co-author registered by the Early Bird Deadline to be included in the Scientific Program and published in the journal Supportive Care in Cancer. Typically, this is the Presenting Author.
  • Submit changes to the Presenting Author by the Early Bird Deadline to events@mascc.org.
  • Ensure that the Presenting Author is registered by Wednesday, June 4, 2025. ***An individual may be a presenting author on a maximum of two (2) abstracts.***
  • Prepare and submit your e-poster by Friday, June 6, 2025.
  • Please review the MASCC/ISOO 2025 Annual Meeting Terms of Service here

Prepare Your E-Poster

DEADLINE FOR E-POSTER SUBMISSION: June 6, 2025.
Presenting Authors will be sent an email in late April by our e-poster partners, SIMUL, with your login details to create and upload your e-poster presentation. Once you log into the platform, you will see a list of the e-posters we are expecting you to upload.

For technical questions or login issues, please contact support@simul-europe.com.

Size & Format:

  • One page only
  • File Format: .PDF
  • Orientation: Landscape (horizontal)
  • Format: 16:9
  • In inches: 18” height x 32” width
  • In cm: 45.72 cm height x 81.28 cm width
  • In pixels: 2000 px height x 1125 px width (minimum requirement)
  • DPI: 300 pixels/inch
  • Recommended Font Size: 16 pt
  • Maximum file size: 5 MB
  • Media: Images, graphs, and tables may be included in the e-poster
  • Video: You may include video with your e-poster (maximum of 1 video per e-poster, maximum file size with video is 40 MB). In order to embed video or audio in your .pdf, please use Adobe Acrobat Pro and only use mp4 files.

 

Additional Notes:

  • Presentations must be prepared in English.
  • All content must be evidence-based, or include an explanation why it is not:
  • Ensure that you note your references including: authors, titles, article title, year, volume, and page numbers in your materials.
    • Evidence must come from systematic reviews/meta-analyses of studies (randomized control trials (RCTs), cohort case control studies), or single, moderate-sized, well designed RCTs, or well-designed, consistent, controlled, non-randomized trials or large cohort studies.
    • Any lack of evidence for assertions or recommendations must be acknowledged.
    • If a single study is the focus or select studies are omitted, the rationale to support this decision must be included.
    • Graphs and charts or other evidence-related materials cannot be altered to highlight one treatment or product.
    • Both potential harms and benefits should be discussed; an efficient way to present these to clinicians is through number needed to treat (NNT) and number needed to harm (NNH), as well as through a presentation of absolute and relative risk reductions.
  • Refer to all medications by the generic name. If brand names must be used, the brand name should appear in parentheses after the generic name. Every drug mentioned should be referred to in a similar manner.
  • Hospital, institution, association, or charitable logos are permitted.
  • Pharmaceutical or corporate commercial logos are only permitted to disclose support of any kind provided by a commercial entity. 
  • Please be mindful of patient privacy rules when sharing any research data. All information shared must remain anonymous.
  • QR codes or website links may be used, however, they cannot link to promotional websites/documents.
  • You will find templates available on SIMUL’s platform. It is not mandatory that you use these.
  •  

What to Expect for Your Presentation

  • E-poster presentations will be held in the Exhibition Hall.
  • You will have a designated e-poster stand number and scheduled time.
  • Please go to your assigned e-poster stand number a minimum of 15 minutes prior to your scheduled presentation time.
  • The e-poster chair will call on you to present your e-poster.
  • You will have three (3) minutes to make your presentation and two (2) minutes for questions.
  • You will stand next to your e-poster displayed on a monitor (no physical printouts required).
  • You will have a tablet linked to the e-poster displayed on the television, which you may “pinch and zoom” to various parts of your e-poster for the viewing delegates.
  • You will speak into a microphone, which will provide audio to headsets for the viewing delegates to hear you more clearly in the busy Exhibition Hall.
  • The Session Chair will facilitate questions from the audience. If English is not your first language and you need assistance, please bring a registered delegate to help with translation.
  • E-posters will be on display at the e-poster stations throughout the entire Annual Meeting. Delegates may view your e-poster at their leisure and will have the opportunity to email you with questions with a “contact author” button available on the e-poster tablets.